Global Cord Blood Corporation [CO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CO Stock Summary

Earnings have grown 7.21% per last year.

In the News

CO Financial details

Company Rating

Market Cap

400.08M

Income

472.81M

Revenue

1.23B

Book val./share

Cash/share

Dividend

Dividend %

Employees

1.2K

Optionable

Shortable

Yes

Earnings

03 Jul 2023

P/E

1.72

Forward P/E

PEG

-2.48

P/S

0.67

P/B

0.47

P/C

P/FCF

2.47

Quick Ratio

10.55

Current Ratio

10.73

Debt / Equity

LT Debt / Equity

EPS (TTM)

3.89

EPS next Y

EPS next Q

EPS this Y

-1.44%

EPS next Y

EPS next 5Y

EPS last 5Y

15.67%

Revenue last 5Y

5.82%

Revenue Q/Q

EPS Q/Q

2.33%

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

16%

ROE

ROC

0.23%

Gross Margin

86%

Oper. Margin

48%

Profit Margin

36%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.6001-3.59

52W High

52W Low

RSI

Rel Volume

Avg Volume

177.42K

Volume

Perf Week

Perf Month

Perf Quarter

Perf Half Y

Beta

-0.044334

Volatility

0%, 0%

Prev Close

Price

Change

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 177.42K
Market Capitalization 400.08M
Employee 1.2K
CEO Ms. Ting Zheng
Headquarters Central,HK
IPO Date 2007-01-25
Website https://www.globalcordbloodcorp.com

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.